Literature DB >> 1338318

Strategies to minimize weight gain after smoking cessation: psychological and pharmacological intervention with specific reference to dexfenfluramine.

B Spring1, R Pingitore, K Kessler.   

Abstract

Cigarette smoking suppresses body weight, discouraging many smokers from trying to quit. Behavioural therapies have so far proved unsuccessful in preventing post-cessation weight gain, and have in fact tended to undercut abstinence from smoking. The mental demands of implementing behavioural weight management strategies may compete with the concentration needed to maintain abstinence from smoking. Consequently, a pharmacological approach offers potential treatment advantages by minimizing the effort needed to achieve weight control. Of the agents found effective in minimizing weight gain, serotoninergic drugs, particularly dexfenfluramine, show special promise because they prevent an increase in caloric intake but do not decrease energy intake below pre-cessation levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1338318

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  3 in total

1.  Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit.

Authors:  T Danielsson; S Rössner; A Westin
Journal:  BMJ       Date:  1999-08-21

2.  Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment.

Authors:  Raymond Niaura; Bonnie Spring; Belinda Borrelli; Donald Hedeker; Michael G Goldstein; Nancy Keuthen; Judy DePue; Jean Kristeller; Judy Ockene; Allan Prochazka; John A Chiles; David B Abrams
Journal:  J Consult Clin Psychol       Date:  2002-08

3.  Effects of phenylpropanolamine on withdrawal symptoms.

Authors:  R C Klesges; L M Klesges; M DeBon; M L Shelton; T R Isbell; M L Klem
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.